heribert voss
Apr 20, 2010
UPDATE: GlaxoSmithKline calls US$152 million global media review, includes China
GLOBAL - GlaxoSmithKline is reviewing its international media planning and buying arrangements, including China.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins